28 October
England and Wales have seen "good progress" on cancer during the last 15 years, but 10,000 cancer deaths each year could still be avoided if early diagnosis was improved, said UK 'cancer tsar' Professor Mike Richards in his Office of Health Economics Lecture in London this week. Professor Richards pointed out that while the UK is doing a little better than average in Europe with regard to incidence of cancer in men, the country is faring less well with incidence in women, and where its five-year survival rates are respectable, one-year survival rates are poor.
If the UK's cancer outcomes were to match those of the more successful European countries, such as Sweden, then cancer deaths could be reduced by 10,000 per year, said Professor Richards. He added that if he could "wave a magic wand" and solve just one of the UK's cancer outcomes problems, it would be the problem of late diagnosis. Under Professor Richards' leadership, the National Awareness and Early Diagnosis Initiative (NAEDI) is now working on ways to facilitate earlier diagnosis, such as targeted public awareness campaigns and improving access to diagnostics for GPs.
Professor Richards was appointed as the UK's first National Cancer Director in October 1999. In 2000 he led the development of the NHS Cancer Plan, the first comprehensive strategy to tackle cancer in England and was subsequently responsible for overseeing its implementation. In June 2008 he was asked by the UK government to lead a review of policy relating to patients who choose to pay privately for drugs that are not funded on the NHS.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.